NOT-HG-23-012: Notice of Need to Expire and Reissue PAR-22-107-Centers Of Excellence In Genomic Science (RM1 Clinical Trial Optional) To Clarify Review Criteria For The Resource Sharing Plan

Notice of Need to Expire and Reissue PAR-22-107- Centers Of Excellence In Genomic Science (RM1 Clinical Trial Optional) To Clarify Review Criteria For The Resource Sharing Plan

Notice Number:

NOT-HG-23-012

Key Dates

Release Date:

November 8, 2022

Related Announcements

PAR-23-098 - Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)

PAR-22-107 - Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional) - Rescinded

Issued by

National Human Genome Research Institute (NHGRI)

Purpose

The purpose of this Notice is to alert applicants of the early expiration of PAR-22-107 Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional) . The funding opportunity announcement (FOA), PAR-22-107, will be rescinded, effective immediately. No further applications will be accepted for consideration under this FOA.

A new FOA, Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional) will be issued to clarify review criteria. Applications for the new FOA will be due on June 22, 2023.

Inquiries

Please direct all inquiries to:

Stephanie A. Morris, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-435-5738
Email: [email protected]